Arora Ritu, Jain Parul, Goyal J L, Gupta Deepa
Guru Nanak Eye Centre, Maulana Azad Medical College, New Delhi, India.
Cornea. 2013 Oct;32(10):1359-64. doi: 10.1097/ICO.0b013e3182a02ddb.
To compare the refractive and topographic changes at 1 year in eyes with early and advanced keratoconus undergoing corneal collagen crosslinking (CXL). A prospective, nonrandomized comparative clinical intervention study.
Thirty eyes of patients with keratoconus underwent CXL. They were divided into 2 groups based on their mean central keratometry: group A [mean central K ≤ 53 diopters (D)] and group B (mean central K > 53 D). Uncorrected visual acuity (UCVA), best-corrected visual acuity (BCVA), refraction, topography, pachymetry, and endothelial cell counts were evaluated at baseline and at 1, 3, 6, and 12 months of follow-up.
The mean baseline logarithm of the minimum angle of resolution (logMAR) UCVA and logMAR BCVA in group A was 1.007 ± 0.30 and 0.566 ± 0.21, respectively. The values improved to 0.727 ± 0.29 (P = 0.001) and 0.306 ± 0.15 (P = 0.001) at 1-year post CXL. The mean baseline logMAR UCVA and logMAR BCVA in group B were 1.040 ± 0.24 and 0.641 ± 0.25, respectively. It changed to 0.953 ± 0.26 (P = 0.054) and 0.633 ± 0.27 (P = 0.891) at 1 year. The improvement in the UCVA and BCVA was statistically significant in group A as compared with that in group B. The mean baseline flattest, steepest, central, and apical keratometry in group A were 48.7 ± 2.5 D, 54.9 ± 3.3 D, 49.5 ± 1.4 D, and 57.3 ± 2.3 D, respectively. At 12 months, the values changed to 47.8 ± 2.4 D, 54.1 ± 3.0 D, 48.8 ± 1.8 D, and 56.2 ± 2.7 D, the change being statistically significant for mean flat and apical K only (P < 0.05). All the 4 indices did not show any statistically significant difference at 12 months in group B (P > 0.05).
Corneal CXL is more effective in improving the refractive and topographical parameters at 1 year when it is performed early in the course of the disease.
比较早期和晚期圆锥角膜患者接受角膜胶原交联(CXL)后1年时的屈光和地形图变化。一项前瞻性、非随机对照临床干预研究。
30例圆锥角膜患者的眼睛接受了CXL。根据平均中央角膜曲率将他们分为2组:A组[平均中央角膜曲率≤53屈光度(D)]和B组(平均中央角膜曲率>53 D)。在基线以及随访的1、3、6和12个月时评估未矫正视力(UCVA)、最佳矫正视力(BCVA)、验光、地形图、角膜厚度测量和内皮细胞计数。
A组的平均基线最小分辨角对数(logMAR)UCVA和logMAR BCVA分别为1.007±0.30和0.566±0.21。CXL术后1年时,这些值分别改善至0.727±0.29(P = 0.001)和0.306±0.15(P = 0.001)。B组的平均基线logMAR UCVA和logMAR BCVA分别为1.040±0.24和0.641±0.25。1年时变为0.953±0.26(P = 0.054)和0.633±0.27(P = 0.891)。与B组相比,A组的UCVA和BCVA改善具有统计学意义。A组的平均基线最平坦、最陡峭、中央和顶端角膜曲率分别为48.7±2.5 D、54.9±3.3 D、49.5±1.4 D和57.3±2.3 D。在12个月时,这些值变为47.8±2.4 D、54.1±3.0 D、48.8±1.8 D和56.2±2.7 D,仅平均平坦和顶端角膜曲率的变化具有统计学意义(P < 0.05)。B组在12个月时所有4项指标均未显示任何统计学显著差异(P > 0.05)。
在疾病早期进行角膜CXL在改善1年时的屈光和地形图参数方面更有效。